Opened in 2026, our PTC Istanbul delivers application-based training, innovative formulation solutions, and concept development.
The laboratory enables faster and closer technical collaboration by combining IMCD’s global expertise with deep local insight. We support the development of solid, liquid, and semi-solid dosage forms, including active pharmaceutical ingredients (APIs), using a risk-based approach aligned with internationally accepted guidelines and Quality by Design (QbD) principles.
Our state-of-the-art, lab-scale equipment enables the manufacturing and testing of oral solid dosage forms (OSDFs), topical formulations, and dispersed systems such as suspensions and emulsions, while our flexible lab setup supports efficient development timeliness and small-batch production.
With strong technical expertise and a collaborative approach, we support you at every stage of your product development.
